Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration

International Journal of Pharmaceutics

Volumn 431, Issue 1-2, 2012, Pages 39-44

  Bacon, Rachel ^a   Newman, Steve ^a   Rankin, Lisa ^a   Pitcairn, Gary ^a   Whiting, Roger ^b  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

^b Roxro Pharma Inc   (United States)

Author keywords

Clearance; Intranasal ketorolac; Nasal deposition

Indexed keywords

KETOROLAC TROMETAMOL; NOSE SPRAY; PENTETATE TECHNETIUM TC 99M;

AEROSOL; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; EPIPHORA; FEMALE; HUMAN; ISOTOPE LABELING; LUNG; MALE; NASAL DEPOSITION; NORMAL HUMAN; NOSE CAVITY; PRIORITY JOURNAL; PULMONARY DEPOSITION; PUMP;

ADMINISTRATION, INTRANASAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; ESOPHAGUS; FEMALE; HUMANS; KETOROLAC TROMETHAMINE; LUNG; MALE; MIDDLE AGED; NASAL CAVITY; POSTURE; STOMACH;

EID: 84861331790     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.04.023     Document Type: Article

References (20)

1. C.R. Brown, and J.P. Mazzulla Comparison of repeat doses of intramuscular ketorolac tromethamine and morphine sulfate for analgesia after major surgery Pharmacotherapy 10 6 (Pt 2) 1990 45S 50S
2. C.R. Brown, and J.E. Moodie Comparison of intravenous ketorolac tromethamine and morphine sulfate in the treatment of postoperative pain Pharmacotherapy 10 6 (Pt 2) 1990 116S 121S
3. C. Brown, and J. Moodie Intranasal ketorolac (ROX-888) for postoperative pain: a phase 3, double-blind, randomized study Pain Medicines 10 6 2009 1106 1114
4. Guidance for Industry Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action 1999 CDRE, US Food and Drug Administration
5. J.C. Gillis, and R.N. Brogden Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management Drugs 53 1 1997 139 188
6. G.M. Grant, and D.R. Mehlisch Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial J. Oral Maxillofac. Surg. 68 5 2010 1025 1031
7. J. Hardy, and S. Lee Intranasal drug delivery by spray and drops J. Pharm. Pharmacol. 37 1985 294 297
8. J. Heyder, and J. Gebhardt Deposition of particles in the human respiratory tract in the size range 0.005 to 15 μm J. Aerosol Sci. 17 1986 811 825
9. D. Jung, and E. Mroszczak Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration Eur. J. Clin. Pharmacol. 35 4 1988 423 425
10. C. Kenyon, and N. Dewsbury Differences in aerodymanic particle size distribution of innovator and generic becomethasone dipropionate aerosols used with and without a large volume spacer Thorax 50 1995 846 850
11. S.D. McAleer, and O. Majid Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers J. Clin. Pharmacol. 47 1 2007 13 18
12. J.E. Moodie, and C.R. Brown The safety and analgesic efficacy of intranasal ketorolac in patients with postoperative pain Anesth. Analg. 107 6 2008 2025 2031
13. S.P. Newman, and F. Moren Deposition pattern from a nasal pump spray Rhinology 25 2 1987 77 82
14. S.P. Newman, and F. Moren Deposition pattern of nasal sprays in man Rhinology 26 2 1988 111 120
15. S.P. Newman, and K.P. Steed The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques J. Pharm. Pharmacol. 46 8 1994 657 660
16. S. Newman, and M. Simpson R. Dalby, P. Byron, J. Peart, J. Suman, S. Farr, Quantification of Lung Deposition and Nasal Mucociliary Clearance for a Nasally Administered Drug Formulation Containing Chitosan 2004 Davis Healthcare Int. Illinois 617 620
17. S.P. Newman, and G.R. Pitcairn Drug delivery to the nasal cavity: in vitro and in vivo assessment Crit. Rev. Ther. Drug Carrier Syst. 21 1 2004 21 66
18. W. Petri, and R. Schmiedel Development of a metered dose nebulizer for intranasal peptide administration Y.W. Chien, Transnasal Systemic Medications 1985 Elsevier Science Publishers Amsterdam 161 181
19. N. Singla, and S. Singla Intranasal ketorolac (ROX-888) for postoperative pain: a phase 3, double-blind, randomized study Curr. Med. Res. Opin. 26 8 2010 1915 1923
20. Task Group on Lung Dynamics Deposition and retention models for internal dosimetry of the human respiratory tract Health Phys. 12 1966 173 207